AI Visibility Scorecard
gmgtrial.com · Healthcare
Somewhat visible. AI bots can read Vor Bio, but it is missing the structured signals that push citation rate above competitors.
Monitoring for AI engine activity
In the Engagemii AEO index
#306,169 of 923,557 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 5.1/10
35
Muse Index Score
iAI agent readiness
Agent-ready · 35/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
UPSTREAM MG Clinical Study · Phase 3 gMG trial, based in Scottsdale, AZ, describes itself simply: "The UPSTREAM MG clinical study is evaluating an investigational medicine called telitacicept in adults living with generalized myasthenia gravis (gMG)." Its AI visibility score is 5.1 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found structured data on the page (MedicalStudy, Organization, WebSite) and a readable heading structure. It is missing an llms.txt file and a sitemap.
Strong · Good · Fair · Weak
Structured Data
Good
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Strong
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.1/10, Vor Bio has a working base to build on - fixable, and the signals above are where to start.
Who may be able to join?
Adults 18 years and older who have been diagnosed with gMG with AChr-Ab or MuSK-Ab may be considered. Final eligibility is determined by the study team during screening.
How long does participation last?
Participation may exceed 84 weeks—about 4 weeks of screening, 24 weeks of first treatment, at least 48 weeks of open-label extension, and about 8 weeks of follow-up. An additional open-label extension may continue for a variable length of time depending on approval.1 Not actual patients.
Where are the study sites?
The UPSTREAM MG study has 25 sites across 17 US states. Final site selection is confirmed by the study team.Hover over a dot to see the state, or enter your ZIP code to jump to the nearest listed site on ClinicalTrials.gov (NCT06456580).Find the closest siteFind site17States25SitesIf you don't see a site near you, email [email protected] reach25 sites · 17 statesEach red pin marks a listed study site.
Is this your brand?
The exact fixes for Vor Bio
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Vor Bio.
Scored by Engagemii on October 6, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/gmgtrial
Cite this score: Engagemii (2026). "AEO Score for Vor Bio." Retrieved from https://engagemii.com/aeo/brands/gmgtrial
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform